BRAF and thyroid cancer: Our results show, for the first time by the analysis of metabolomic profiles, that the pro-oxidant effect of vitamin C in BRAF mutant thyroid cancer cells induces the inhibition of glycolysis and alteration of TCA cycle via NAD+ depletion, leading to cell death.